BIIB015
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIIB015, covering 2013-09-16 to 2013-09-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors [Phase 1]